ARCHIVES

NCI/DCT Advisors Approve Concept For $15 Million Lymphoma Studies

This article is from The Cancer Letter archive.

Vol. 16 No. 24 | June 15, 1990

Download PDF Visit The Full Archive

Related Articles

NCI Committee Attempts To Redesign Cooperative Groups Without Doing Harm

June 12, 1998

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012

NCI contract Awards; RFPs Available; RFAs, PA Available.

October 14, 1994

NCI Supercomputer Upgrading Supported By DCBD Board; Could Cost $40 Million Plus Renovations

March 3, 1989

Vaccine Prevented Cervical Pre-Cancers, Non-Invasive Cancers In Phase III Trial

October 28, 2005

NCI advisors seek comment on clinical trials system, until Jan. 15.

December 10, 2004